Abstract
Background/Objective:
Previous clinical trials have documented that soy protein reduces low-density lipoprotein cholesterol and increases high-density lipoprotein (HDL) cholesterol compared with milk protein. However, the effect of soy protein on lipids compared with carbohydrate has not been not well studied. We examined the effect of soy and milk protein supplementation on lipids and lipoproteins compared with carbohydrate among adults without hypercholesterolemia.
Subjects/Methods:
We conducted a randomized, double-blind, 3-phase crossover trial among 352 US adults with serum total cholesterol level of <240 mg/dl from September 2003 to April 2008. Trial participants were assigned to 40 g/day supplementation of soy protein, milk protein or complex carbohydrate from wheat each for 8 weeks in random order with a 3-week washout period between interventions. Overnight fasting blood samples were collected at the termination of each intervention phase.
Results:
Compared with carbohydrate, soy protein supplementation was significantly associated with a net change (95% confidence interval (CI)) in total cholesterol and total/HDL cholesterol ratio of −3.97 mg/dl (−7.63 to −0.31, P=0.03) and −0.12 (−0.23 to −0.01, P=0.03), respectively. Compared with milk protein, soy protein supplementation was significantly associated with a net change (95% CI) in HDL and total/HDL cholesterol ratio of 1.54 mg/dl (0.63 to 2.44, P=0.0009) and −0.14 (−0.22 to −0.05, P=0.001), respectively. Compared with carbohydrate, milk protein supplementation was significantly associated with a net change (95% CI) in HDL of −1.13 mg/dl (−2.05 to −0.22, P=0.02).
Conclusions:
This randomized controlled trial indicates that soy protein, but not milk protein, supplementation improves the lipid profile among healthy individuals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aavik E, du Toit D, Myburgh E, Frosen J, Hayry P (2001). Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury. Mol Cell Endocrinol 182, 91–98.
Anderson JW, Johnstone BM, Cook-Newell ME (1995). Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276–282.
Barrett-Conner E, Stuenkel C (1999). Hormones and heart disease in women: heart and estrogen/progestin replacement study in perspective. J Clin Endocrinol Metab 84, 1848–1853.
Baum JA, Teng H, Erdman Jr JW, Weigel RM, Klein BP, Persky VW et al. (1998). Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68, 545–551.
Beaglehole R (1990). International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev 12, 1–15.
Carroll KK. (1991). Review of clinical studies on cholesterol-lowering response to soy protein. J Am Diet Assoc 91, 820–827.
Clerici C, Setchell KDR, Battezzati PM, Pirro M, Giuliano V, Asciutti S et al. (2007). Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr 137, 2270–2278.
Crouse 3rd JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL (1999). A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159, 2070–2076.
De Caterina R, Scarano M, Marfisi R, Lucisano G, Palma F, Tatasciore A et al. (2010). Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials. J Am Coll Cardiol 55, 198–211.
Erdman Jr JW. (2000). AHA Science Advisory: soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 102, 2555–2559.
Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18, 499–502.
Gardner CD, Newell KA, Cherin R, Haskell WL (2001). The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 73, 728–735.
Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB et al. (2003). Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290, 891–897.
Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association (2004). Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227–239.
He J, Wofford MR, Reynolds K, Chen J, Chen C-S, Myers L et al. (2011). Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial. Circulation 124, 589–595.
Hodges YK, Tung L, Yan XD, Graham JD, Horwitz LD (2000). Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 101, 1792–1798.
Jenkins DJA, Mirrahimi A, Srichaikul K, Berryman CE, Wang L, Carleton A et al. (2010). Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 140, 2302S–2311S.
Joswig M, Hach-Wunderle V, Ziegler R, Nawroth PP (1999). Postmenopausal hormone replacement therapy and the vascular wall: mechanisms of 17 ß-estradiol's effects on vascular biology. Exp Clin Endocrinol Diabetes 107, 477–487.
Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252–4263.
LaRosa JC, He J, Vupputuri S (1999). Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282, 2340–2346.
Merz-Demlow BE, Duncan AM, Wangen KE, Xu X, Carr TP, Phipps WR et al. (2000). Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 71, 1462–1469.
Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J (2006). A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 98, 633–640.
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2011). Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123, e18–e209.
Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. American Heart Association Nutrition Committee (2006). Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113, 1034–1044.
Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D et al. Atherosclerosis Risk in Communities Study Group (2001). Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104, 1108–1113.
Srinivasan SR, Berenson GS (1983). Serum lipoproteins in children and methods for study. In: Lewis LA (ed). CRC Handbook of Electrophoresis. Vol. 3, Lipoprotein Methodology and Human Studies. CRC Press: Boca Raton, FL, USA, pp 185–203.
Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD (2000). Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284, 311–318.
Wilson PW, Hoeg JM, D’Agostino RB, Silbershatz H, Belanger AM, Poehlmann H et al. (1997). Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 337, 516–522.
Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H et al. (2003). Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133, 2874–2878.
Acknowledgements
This work was supported by a research grant (R01 HL68057) from the National Heart, Lung and Blood Institute of National Institutes of Health, Bethesda, MD, USA. The study supplements were provided for the study by Solae, LLC (St Louis, MO, USA).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Contributors: MRW, KR, JC, DWJ, PKW and JH designed research; MRW, KR, JC, JX and JH conducted research; CMR, CSC, LM and JH analyzed data; CMR and JH wrote the paper; JH had primary responsibility for the final content. All authors read and approved the final manuscript.
Rights and permissions
About this article
Cite this article
Wofford, M., Rebholz, C., Reynolds, K. et al. Effect of soy and milk protein supplementation on serum lipid levels: a randomized controlled trial. Eur J Clin Nutr 66, 419–425 (2012). https://doi.org/10.1038/ejcn.2011.168
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2011.168
Keywords
This article is cited by
-
Comparing isolated soy protein with flaxseed oil vs isolated soy protein with corn oil and wheat flour with corn oil consumption on muscle catabolism, liver function, blood lipid, and sugar in burn patients: a randomized clinical trial
Trials (2018)
-
Some nutritional supplements may have modest beneficial effects on lipid levels, but the effects of most are negligible
Drugs & Therapy Perspectives (2015)
-
The Effect of Nutritional Supplements on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I
American Journal of Cardiovascular Drugs (2014)